RecruitingNot applicableNCT06424327

A Registry for People With Lung Cancer

Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.

Checked against the public recordLast updated Aug 7, 2026 · Source: ClinicalTrials.gov

StatusRecruiting
PhaseNot applicable
U.S. locations18
SponsorMemorial Sloan Kettering Cancer Center
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Other: Patient-Reported Outcomes Measurement Information System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Age ≥18 years * Patients suitable for segmentectomy, according to the treating surgeon * Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition o Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology Exclusion Criteria: * Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years * History of chemotherapy or radiation therapy for a previous lung cancer * Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery * Carcinoid tumors * History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix * Actively receiving treatment for other malignancies * Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis. * Multi-segmental resection from the same lobe is not a criterion for exclusion.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Arizona (Data Collection Only)Tucson, Arizona
  • University of California San Diego (Data collection)San Diego, California
  • Rush University Medical Center (Data collection only)Chicago, Illinois
  • Endeavor HealthEvanston, Illinois
  • University of Michigan (Data Collection Only)Ann Arbor, Michigan
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)Commack, New York
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 7, 2026. Always confirm current availability with the study team.

View original record ↗